Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas

May 26, 2017 updated by: Mead Johnson Nutrition
This clinical trial will compare the growth and tolerance of infants who consume an investigational cow's milk-based infant formula to those who consume a marketed cow's milk-based infant formula through approximately 4 months of age.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35205
        • Birmingham Pediatric Associates
      • Dothan, Alabama, United States, 36305
        • Southeastern Pediatric Associates
    • Arkansas
      • Fayetteville, Arkansas, United States, 72703
        • Northwest Arkansas Pediatric Clinic
      • Jonesboro, Arkansas, United States, 72401
        • The Children's Clinic of Jonesboro, P.A.
    • Connecticut
      • Norwich, Connecticut, United States, 06360
        • Norwich Pediatric Group, P.C.
    • Florida
      • Lake Mary, Florida, United States, 32746
        • Altamonte Pediatric Associates
    • Indiana
      • Evansville, Indiana, United States, 47725
        • Deaconess Clinical Research
    • Kentucky
      • Bardstown, Kentucky, United States, 40004
        • Kentucky Pediatrics/Adult Research
      • Owensboro, Kentucky, United States, 42303
        • Owensboro Pediatrics
    • Ohio
      • Cincinnati, Ohio, United States, 45245
        • Pediatric Associates of Mt. Carmel, Inc.
      • Dayton, Ohio, United States, 45414
        • Ohio Pediatric Research Association
      • Fairfield, Ohio, United States, 45014
        • Pediatric Associates of Fairfield, Inc.
      • Westlake, Ohio, United States, 44145
        • UHMP Comprehensive Pediatrics
    • South Carolina
      • Charleston, South Carolina, United States, 29414
        • Coastal Pediatric Research
    • Tennessee
      • Jackson, Tennessee, United States, 38305
        • The Jackson Clinic - North Jackson
      • Kingsport, Tennessee, United States, 37660
        • Holston Medical Group
    • Texas
      • Longview, Texas, United States, 75605
        • DCOL Center for Clinical Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 week to 2 weeks (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Singleton 10-14 days of age at randomization
  • Term infant with birth weight of minimum of 2500 grams
  • Solely formula fed
  • Signed informed consent and protected health information

Exclusion Criteria:

  • History of underlying metabolic or chronic disease, anemia, or immune compromise
  • Feeding difficulties or formula intolerance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
Marketed cow's milk-based infant formula
Experimental: Investigational
Cow's milk-based infant formula with added nutrients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Rate of body weight gain from 14 to 120 days of age
Time Frame: 3.5 months
3.5 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Recall of infant formula at each study visit
Time Frame: Up to 3.5 months
Up to 3.5 months
Body length measured at each study visit
Time Frame: Up to 3.5 months
Up to 3.5 months
Recall of stool characteristics questionnaire measured at each study visit
Time Frame: Up to 3.5 months
Up to 3.5 months
Head circumference measured at each study visit
Time Frame: Up to 3.5 months
Up to 3.5 months
Recall of gastrointestinal tolerance questionnaire at each study visit
Time Frame: Up to 3.5 months
Up to 3.5 months
Medically confirmed adverse events collected throughout the study period
Time Frame: Up to 3.5 months
Up to 3.5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2016

Primary Completion (Anticipated)

March 1, 2018

Study Completion (Anticipated)

April 1, 2018

Study Registration Dates

First Submitted

August 3, 2016

First Submitted That Met QC Criteria

August 4, 2016

First Posted (Estimate)

August 9, 2016

Study Record Updates

Last Update Posted (Actual)

May 31, 2017

Last Update Submitted That Met QC Criteria

May 26, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 3388-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Growth

Clinical Trials on Marketed cow's milk-based infant formula

Subscribe